Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-12-11 Sale | 2024-12-13 6:20 pm | Tempus AI Inc. | TEM | Epstein David R Director | 620 | $41.81 | $25,922 | 27,894 (Direct) | View |
2023-11-10 Sale | 2023-11-13 8:02 pm | Seagen Inc. | SGEN | Epstein David R CEO | 10,620 | $213.01 | $2,262,166 | 136,598 (Direct) | View |
2022-05-27 Purchase | 2022-05-31 4:07 pm | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 17,123 | $1.46 | $25,000 | 84,080 (Direct) | View |
2022-04-21 Purchase | 2022-04-22 6:07 pm | Rubius Therapeutics Inc. | RUBY | Epstein David R Director | 30,000 | $1.4443 | $43,329 | 4,720,012 (Direct) | View |
2022-03-16 Purchase | 2022-03-18 08:30 am | Axcella Health Inc. | AXLA | Epstein David R Director | 26,178 | $1.91 | $50,000 | 161,162 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-13 Option Award | 2024-06-17 9:45 pm | N/A N/A | Tempus AI Inc. | TEM | Epstein David R Director | 28,514 | $0 | 28,514 (Direct) | View |
2023-12-14 Disposition | 2023-12-15 6:29 pm | N/A 2032-11-09 | Seagen Inc. | SGEN | Epstein David R CEO | 627,188 | $0 | 0 (Direct) | View |
2023-12-14 Disposition | 2023-12-15 6:29 pm | N/A N/A | Seagen Inc. | SGEN | Epstein David R CEO | 16,407 | $229 | 0 (Direct) | View |
2023-08-15 Option Award | 2023-08-17 9:14 pm | N/A N/A | Seagen Inc. | SGEN | Epstein David R Chief Executive Officer | 39,650 | $0 | 147,218 (Direct) | View |
2022-11-09 Option Award | 2022-11-14 5:45 pm | N/A 2032-11-09 | Seagen Inc. | SGEN | Epstein David R Chief Executive Officer | 750,736 | $0 | 750,736 (Direct) | View |
2022-07-13 Option Award | 2022-07-15 6:00 pm | N/A 2032-07-12 | Senti Biosciences Inc. | SNTI | Epstein David R Director | 125,000 | $0 | 125,000 (Direct) | View |
2022-06-30 Exercise | 2022-06-30 4:52 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 4,927 | $0 | 93,932 (Direct) | View |
2022-06-10 Option Award | 2022-06-13 4:41 pm | N/A 2032-06-10 | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-08 Exercise | 2022-06-10 9:22 pm | N/A N/A | Dynamics Special Purpose Corp. | SNTI | Epstein David R Director | 112,519 | $0 | 123,252 (Indirect) | View |
2022-06-08 Option Award | 2022-06-10 9:22 pm | N/A N/A | Dynamics Special Purpose Corp. | SNTI | Epstein David R Director | 112,519 | $0 | 123,252 (Direct) | View |
2022-05-19 Option Award | 2022-06-03 4:30 pm | N/A N/A | Axcella Health Inc. | AXLA | Epstein David R Director | 47,059 | $0 | 209,756 (Direct) | View |
2022-05-31 Exercise | 2022-06-01 4:12 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 4,925 | $0 | 93,932 (Direct) | View |
2022-05-12 Option Award | 2022-05-13 4:20 pm | N/A 2032-05-11 | Rubius Therapeutics Inc. | RUBY | Epstein David R Director | 499,762 | $0 | 499,762 (Direct) | View |
2022-05-02 Exercise | 2022-05-02 4:03 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 4,926 | $0 | 76,809 (Direct) | View |
2022-03-31 Exercise | 2022-04-01 4:05 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 4,926 | $0 | 76,809 (Direct) | View |
2022-03-18 Exercise | 2022-03-21 4:30 pm | N/A N/A | Axcella Health Inc. | AXLA | Epstein David R Director | 1,535 | $0 | 212,697 (Direct) | View |
2022-03-17 Option Award | 2022-03-21 4:30 pm | N/A 2032-03-16 | Axcella Health Inc. | AXLA | Epstein David R Director | 50,000 | $0 | 212,697 (Direct) | View |
2022-02-28 Exercise | 2022-03-01 4:07 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 4,926 | $0 | 76,809 (Direct) | View |
2022-02-18 Exercise | 2022-02-23 4:19 pm | N/A N/A | Axcella Health Inc. | AXLA | Epstein David R Director | 1,534 | $0 | 136,519 (Direct) | View |
2022-01-31 Exercise | 2022-01-31 5:06 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 4,925 | $0 | 76,809 (Direct) | View |
2022-01-18 Exercise | 2022-01-20 4:30 pm | N/A N/A | Axcella Health Inc. | AXLA | Epstein David R Director | 1,535 | $0 | 136,519 (Direct) | View |
2021-12-31 Exercise | 2022-01-03 4:23 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 4,926 | $0 | 76,809 (Direct) | View |
2021-12-17 Exercise | 2021-12-20 4:15 pm | N/A N/A | Axcella Health Inc. | AXLA | Epstein David R Director | 1,535 | $0 | 136,519 (Direct) | View |
2021-11-30 Exercise | 2021-12-01 4:39 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 4,926 | $0 | 76,809 (Direct) | View |
2021-11-18 Exercise | 2021-11-22 6:04 pm | N/A N/A | Axcella Health Inc. | AXLA | Epstein David R Director | 1,534 | $0 | 136,519 (Direct) | View |
2021-11-01 Exercise | 2021-11-01 5:22 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 4,925 | $0 | 76,809 (Direct) | View |
Ownership | 2021-10-26 8:57 pm | N/A N/A | Opy Acquisition Corp. I | OHAA | Epstein David R Director | 0 | $0 | 0 (Direct) | View |
2021-10-18 Exercise | 2021-10-19 4:31 pm | N/A N/A | Axcella Health Inc. | AXLA | Epstein David R Director | 1,535 | $0 | 136,519 (Direct) | View |
2021-10-01 Exercise | 2021-10-01 4:42 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 4,927 | $0 | 76,809 (Direct) | View |
2021-09-17 Exercise | 2021-09-20 4:31 pm | N/A N/A | Axcella Health Inc. | AXLA | Epstein David R Director | 1,535 | $0 | 136,519 (Direct) | View |
2021-09-03 Exercise | 2021-09-03 4:55 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 9,850 | $0 | 76,809 (Direct) | View |
2021-08-18 Exercise | 2021-08-19 4:15 pm | N/A N/A | Axcella Health Inc. | AXLA | Epstein David R Director | 1,534 | $0 | 136,519 (Direct) | View |
2021-07-16 Exercise | 2021-07-20 4:31 pm | N/A N/A | Axcella Health Inc. | AXLA | Epstein David R Director | 1,535 | $0 | 136,519 (Direct) | View |
2021-06-30 Option Award | 2021-07-02 4:25 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Epstein David R Director | 59,109 | $0 | 59,109 (Direct) | View |
2021-06-18 Exercise | 2021-06-21 5:42 pm | N/A N/A | Axcella Health Inc. | AXLA | Epstein David R Director | 1,535 | $0 | 136,519 (Direct) | View |
Ownership | 2021-05-25 8:21 pm | N/A N/A | Dynamics Special Purpose Corp. | DYNS | Epstein David R Director | 0 | $0 | 123,252 (Indirect) | View |